Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05707156 · ClinicalTrials.gov registry record
Prospective Observational Study on the Incidence of Opportunistic Fungal Infections
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 12,032
- Enrollment target
NCT05707156: Completed study, sponsored by University of Colorado, Denver.
NCT05707156 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 12,032 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05707156 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 12,032 participants
- Enrollment target
Study Summary
Corticosteroids exposure is a common risk factor for invasive fungal infections. Systemic corticosteroid therapy treats several medical conditions, including rejection in solid organ transplant recipients, malignancy, and autoimmune or inflammatory diseases. Corticosteroid exposure is a well-known risk factor for developing PJP. Still, it remains unclear how prior corticosteroid exposure influences the presentation, severity, and mortality of opportunistic fungal infections. The investigators aim to prospectively characterize the corticosteroid use as a dose response to inform risk of invasive fungal infections.
Primary Outcome
Number of cases of Pneumocystis jirovecii pneumonia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,032 participants |
| Start Date | 2023-07-05 |
| Est. Completion | 2024-01-05 |
What the finished NCT05707156 record still lists
NCT05707156 is an observational study that tracks outcomes without assigning an intervention. Its 12,032 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT05707156 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05707156 about?
NCT05707156 is a clinical study titled "Prospective Observational Study on the Incidence of Opportunistic Fungal Infections". Corticosteroids exposure is a common risk factor for invasive fungal infections. Systemic corticosteroid therapy treats several medical conditions, including rejection in solid organ transplant recipients, malignancy, and autoimmune or inflammatory diseases. Corticosteroid exposure is a well-known r...
What is the current status of trial NCT05707156?
This trial is currently completed. The enrollment target is 12,032 participants. The study started on 2023-07-05. Estimated completion is 2024-01-05.
Who is sponsoring clinical trial NCT05707156?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- NCT04937868 · 12,000 participants
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
- NCT06059963 · 12,000 participants
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
- NCT06273618 · 12,000 participants · NA
iLookOut Micro-learning to Improve Knowledge Retention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI